Last we have Dr. Daniel Brodie with "ECMO in COVID-19" #CHEST2021 25/
This study organized ECMO availability in Paris during COVID-19. 54% 90 day mortality. Mortality worse for older patents, at lower volume centers, and later ECMO cannulation after intubation. #CHEST2021 26/
This study had a 38.8% mortality rate. #CHEST2021 27/
This trial looked at a trial of ECMO vs no ECMO. The ECMO group had a lower mortality rate. #CHEST2021 28/
This cohort had a 37.4% mortality rate with ECMO. #CHEST2021 29/
Complications of ECMO. No difference in complications in COVID-19 vs other patients, except based on the time you are on ECMO. #CHEST2021 30/
Factors associated with an increased risk of in-hospital mortality include age, immunocompromised status, cardiac arrest, and chronic respiratory failure. #CHEST2021 31/
This study in Germany had higher mortality rates. #CHEST2021 32/
This meta-analysis showed a pooled in-hospital mortality of 37.1%. #CHEST2021 33/
I'm excited to jump into the Wellness Zone next with Dahlia El Gazzar (@DahliaElGazzar) speaking on "Practicing Gratitude for the Present: The Power of Gratitude." #CHEST2021 1/
The next #CHEST2021 session for tweet-ucation is "COVID-19: Other Considerations in Management"! 1/
Derlis Fleitas Sosa talks on "Significant dyspnea in post-acute COVID-19 is associated with abnormal pulmonary vasculature on CT during the acute phase." #CHEST2021 2/